4
Changes in Ownership
ATOSSA THERAPEUTICS, INC. Filed Acc 0001437749-20-007630
Options or other derivatives
- CFO, Gen Counsel and Secretary acquired 590,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Guse Kyle CFO, Gen Counsel and Secretary | 2020-04-09 | Grant or award · Stock Option (Right to Buy) | +195,000 | 195,000 | D | ||
| Guse Kyle CFO, Gen Counsel and Secretary | 2020-04-09 | Grant or award · Stock Option (Right to Buy) | +395,000 | 395,000 | D | ||
Loading xslF345X03/rdgdoc.xml…